(NaturalNews) A substudy of the PROTEUS trial found that 63% of men who received the hormone therapy apalutamide plus androgen-deprivation therapy before and after …
PROTEUS Substudy Reports 63% of Prostate Cancer Patients Avoid Recurrence With Combination Therapy
Estimated read time
1 min read
